DEXIRON 50 MG
IRON (IRON DEXTRAN COMPLEX) : 50 MG · DIN 02205963 · AMERICAN REGENT, INC
Health Canada status: CANCELLED POST MARKET
What is DEXIRON?
DEXIRON 50 MG contains IRON (IRON DEXTRAN COMPLEX) : 50 MG. It is listed in the Health Canada Drug Product Database under DIN 02205963, held by AMERICAN REGENT, INC, supplied as SOLUTION for INTRAMUSCULAR ; INTRAVENOUS administration. Health Canada currently lists it as cancelled post market, status dated 12-May-2022. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is DEXIRON used for?
Treatment of documented iron deficiency in patients in whom oral iron administration is unsatisfactory or impossible.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02205963 |
|---|---|
| Brand name | DEXIRON |
| Generic / active ingredient | IRON (IRON DEXTRAN COMPLEX) : 50 MG |
| Manufacturer | AMERICAN REGENT, INC |
| Strength | 50 MG |
| Dosage form | SOLUTION |
| Route of administration | INTRAMUSCULAR ; INTRAVENOUS |
| Schedule | Prescription |
| ATC code | B03AC IRON, PARENTERAL PREPARATIONS |
| AHFS class | 20:04.04 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 12-May-2022 |
| Original market date | 1996-09-06 00:00:00 |
How is it administered?
Discontinue oral iron. Administer 0.5 mL test dose first. IV: slow rate (max 1 mL/min). IM: Z-track technique into upper outer quadrant of buttock. Daily dose usually max 2 mL.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Store at room temperature, 15°-30°C (59°-86°F). Protect from excessive heat. Do not freeze.
How is it supplied?
2 mL single-dose vials supplied in cartons of 10 vials.
Contraindications
Hypersensitivity to the drug product. All anemias not associated with iron deficiency.
Warnings and precautions
Serious hypersensitivity/fatal anaphylactic reactions reported. Use only where resuscitative equipment is available. Risk of injection site carcinogenesis. Avoid Total Dose Infusion (TDI).
What can be used instead?
Other Canadian products sharing ATC code B03AC IRON, PARENTERAL PREPARATIONS. 5 of 10 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| FERINJECT | 50 MG | DISPERSION | VIFOR (INTERNATIONAL) INC. | MARKETED | DIN 02546078 |
| FERRLECIT | 12.5 MG | SOLUTION | SANOFI-AVENTIS CANADA INC | MARKETED | DIN 02243333 |
| MONOFERRIC | 100 MG | SOLUTION | Pfizer Canada Ulc | MARKETED | DIN 02477777 |
| PMS-IRON SUCROSE | 20 MG | SOLUTION | PHARMASCIENCE INC | MARKETED | DIN 02502917 |
| VENOFER | 20 MG | SOLUTION | FRESENIUS MEDICAL CARE CAN INC | MARKETED | DIN 02243716 |
| FERAHEME | 30 MG | SOLUTION | AMAG PHARMACEUTICALS INC | CANCELLED POST MARKET | DIN 02377217 |
| INFUFER | 50 MG | LIQUID | SANDOZ CANADA INCORPORATED | CANCELLED POST MARKET | DIN 02221780 |
| JECTOFER 50 MG/ML | 100 MG | LIQUID | ASTRAZENECA CANADA INC | CANCELLED POST MARKET | DIN 00001910 |
| TRIFERIC AVNU | 1.5 MG | SOLUTION | ROCKWELL MEDICAL INC | CANCELLED PRE MARKET | DIN 02515334 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.